Literature DB >> 2037377

Expression and immunogenicity of a streptococcal M protein epitope inserted in Salmonella flagellin.

S M Newton1, M Kotb, T P Poirier, B A Stocker, E H Beachey.   

Abstract

A synthetic 48-bp oligonucleotide specifying the N-terminal 15 amino acids of M protein of Streptococcus pyogenes type 5 (plus a CTA codon, to terminate translation of genes with the insert in reverse orientation) was inserted by blunt-end ligation at the site of the 48-bp EcoRV deletion in the Salmonella flagellin gene in plasmid pLS408 (S. M. C. Newton, C. O. Jacob, and B. A. D. Stocker, Science 244: 70-72, 1989). The resulting plasmid was transferred from Escherichia coli via a restriction-negative Salmonella typhimurium strain into an aromatic-compound-dependent, flagellin-negative live-vaccine strain of Salmonella dublin to produce strain SL7127, which was motile. Expression of the inserted epitope in flagellin and its exposure at the flagellar filament surface were shown by immunoblotting and by the reaction of flagellate bacteria (immobilization, immunogold labeling) with antibody raised by injection of the corresponding synthetic peptide, S-M5(1-15). Rabbits immunized by injection of the live-vaccine strain with flagella composed of the chimeric flagellin or by injection of concentrated flagella from such bacteria developed antibodies reactive in an enzyme-linked immunosorbent assay with peptide S-M5(1-15) and with the large peptic-digest peptide pepM5. These antibodies were opsonic for type 5 streptococci. Mice that were given parenteral live SL7127 (six doses, each 1 x 10(6) to 2 x 10(6), over 8 weeks) developed titers of ca. 12,800 for the M5-specific peptides and opsonizing activity for type 5 streptococci but not for type 24 streptococci. Sera from mice similarly immunized with a control live vaccine strain without an insert in the flagellin gene did not react with the M5-specific antigens. All of the five mice given the control strain, without an insert, died after challenge with type 5 streptococci or type 24 streptococci; by contrast, four of the five mice given strain SL7127, with an insert, survived the M5 challenge, but none of the five challenged with the type 24 strain survived. Therefore, our study shows that an M protein epitope can be expressed in the context of an unrelated protein and maintain its immunogenicity. Furthermore, we demonstrate that mice can be protected against a Streptococcus pyogenes type 5 challenge by immunization with a Salmonella live vaccine with flagella made of flagellin with an insert carrying a protective epitope of M5 protein but without the cross-reactive epitopes of the complete protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2037377      PMCID: PMC257981          DOI: 10.1128/iai.59.6.2158-2165.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  IMMUNOLOGIC RELATION OF STREPTOCOCCAL AND TISSUE ANTIGENS. I. PROPERTIES OF AN ANTIGEN IN CERTAIN STRAINS OF GROUP A STREPTOCOCCI EXHIBITING AN IMMUNOLOGIC CROSS-REACTION WITH HUMAN HEART TISSUE.

Authors:  M H KAPLAN
Journal:  J Immunol       Date:  1963-04       Impact factor: 5.422

2.  Current knowledge of type-specific M antigens of group A streptococci.

Authors:  R C LANCEFIELD
Journal:  J Immunol       Date:  1962-09       Impact factor: 5.422

3.  Transformation of Salmonella typhimurium by plasmid deoxyribonucleic acid.

Authors:  E M Lederberg; S N Cohen
Journal:  J Bacteriol       Date:  1974-09       Impact factor: 3.490

4.  Identification of amino acid changes in serological mutants of the i flagellar antigen of Salmonella typhimurium.

Authors:  T M Joys; J F Martin
Journal:  Microbios       Date:  1973

5.  Cross-reaction of group A streptococci and heart tissue: varying serologic specificity of cross-reactive antisera and relation to carrier-hapten specificity.

Authors:  M H Kaplan
Journal:  Transplant Proc       Date:  1969-12       Impact factor: 1.066

6.  Heart-reactive antibody associated with rheumatic fever: characterization and diagnostic significance.

Authors:  J B Zabriskie; K C Hsu; B C Seegal
Journal:  Clin Exp Immunol       Date:  1970-08       Impact factor: 4.330

7.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.

Authors:  E Engvall; P Perlmann
Journal:  Immunochemistry       Date:  1971-09

8.  Study on streptococcus group A antigens common with heart tissue elements.

Authors:  I M Lyampert; O I Vvedenskaya; T A Danilova
Journal:  Immunology       Date:  1966-10       Impact factor: 7.397

9.  Electron microscopic studies on streptococci. I. M antigen.

Authors:  J Swanson; K C Hsu; E C Gotschlich
Journal:  J Exp Med       Date:  1969-11-01       Impact factor: 14.307

10.  Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen.

Authors:  E H Beachey; G H Stollerman; E Y Chiang; T M Chiang; J M Seyer; A H Kang
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

View more
  15 in total

1.  Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni.

Authors:  T Ben-Yedidia; R Tarrab-Hazdai; D Schechtman; R Arnon
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 2.  Effects of flagellin on innate and adaptive immunity.

Authors:  Anna N Honko; Steven B Mizel
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  Identification of the domain which determines the g,m serotype of the flagellin of Salmonella enteritidis.

Authors:  A J van Asten; K A Zwaagstra; M F Baay; J G Kusters; J H Huis in't Veld; B A van der Zeijst
Journal:  J Bacteriol       Date:  1995-03       Impact factor: 3.490

4.  Hypervariable region IV of Salmonella gene fliCd encodes a dominant surface epitope and a stabilizing factor for functional flagella.

Authors:  X S He; M Rivkina; B A Stocker; W S Robinson
Journal:  J Bacteriol       Date:  1994-04       Impact factor: 3.490

5.  CS31A capsule-like antigen as an exposure vector for heterologous antigenic determinants.

Authors:  F Bousquet; C Martin; J P Girardeau; M C Méchin; M Der Vartanian; H Laude; M Contrepois
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Molecular analyses of the Salmonella g. . . flagellar antigen complex.

Authors:  B J Masten; T M Joys
Journal:  J Bacteriol       Date:  1993-09       Impact factor: 3.490

Review 7.  Reevaluating the hype: four bacterial metabolites under scrutiny.

Authors:  E E Fröhlich; R Mayerhofer; P Holzer
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

8.  Protective Immunity and Reduced Renal Colonization Induced by Vaccines Containing Recombinant Leptospira interrogans Outer Membrane Proteins and Flagellin Adjuvant.

Authors:  D Monaris; M E Sbrogio-Almeida; C C Dib; T A Canhamero; G O Souza; S A Vasconcellos; L C S Ferreira; P A E Abreu
Journal:  Clin Vaccine Immunol       Date:  2015-06-24

9.  Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice.

Authors:  K L Karem; S Chatfield; N Kuklin; B T Rouse
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  Host and bacterial factors affecting induction of immune responses to flagellin expressed by attenuated Salmonella vaccine strains.

Authors:  M E Sbrogio-Almeida; T Mosca; L M Massis; I A Abrahamsohn; L C S Ferreira
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.